Friday, November 18, 2022

Strides Pharma arms gets USFDA approval for potassium-deficiency drug

Strides Pharma arms gets USFDA approval for potassium-deficiency drug The approval granted by the US Food Drug Administration (USFDA) to Strides Pharma Global Pte Ltd, Singapore, is for potassium chloride oral solution of strength 40 mEq/15mL (20 per cent), Strides Pharma Science (Strides) said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/1qaDPf7

No comments:

Post a Comment

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...